Picture 1 of 1

Stock photo
Stock photo
Drugs for HER-2-positive Breast Cancer - 9783034600934 - Picture 1 of 1

Drugs for HER-2-positive Breast Cancer by Rupert Bartsch, Christoph C. Zielinski, Thomas W. Grunt, Maria Sibilia (Hardcover, 2011)

Be the first towrite a review.
  • BOOKS etc. (454982)
  • 99.2% positive Feedback
Price:
£103.81
Free postage
Estimated delivery Mon, 13 May - Thu, 16 May
Returns:
60 days return. Buyer pays for return postage.
Condition:
New
ISBN-13: 9783034600934, 978-3034600934. Drugs for HER-2-positive Breast Cancer. Growth factor receptors have long been known to drive malignant transformation and cancer progression. Recent clinical studies have revealed that these refractory tumors are still responsive to inhibition of the HER receptor family using dual HER-1/-2 inhibitors such as lapatinib (Tykerb/Tyverb).